Search

everythinglearnresearchcommunity

for

Search:↓

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

Pilomatricomas are often linked to genetic syndromes, especially Apert syndrome, and genetic analysis is crucial for diagnosis.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.